Relevance of BRCA1 BayesDel evidence calibration to "Interpret BRCA1/BRCA2 germline variants"
- Use case
- Interpret BRCA1/BRCA2 germline variants
- Assessed by
- BRCA1 BayesDel evidence calibration
- Relevance
- Proxy evidence
- Endpoint
- Functional-reference likelihood ratios for computational evidence weights
A gene-specific evidence input calibration relevant to BRCA review; it does not measure full clinical classification or review effort.
1 reviewed evaluation
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Functional-reference likelihood ratios for computational evidence weights Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:uc-clinical-20260930-enigma-brca1-protocol Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations2 values
| Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records19 values
| Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale A gene-specific evidence input calibration relevant to BRCA review; it does not measure full clinical classification or review effort. Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations. Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance proxy Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Original source · 2024 final article; reported VCEP specifications v1.0
Technical metadata and extraction receipts
Stable ID: use-case-mapping-20260930-343-2b9e45a46d4b
- field
- links:assessed_by:uc-clinical-20260930-enigma-brca1-protocol
- value
- uc-clinical-20260930-enigma-brca1-protocol
- relevance
- proxy
- endpoint
- Functional-reference likelihood ratios for computational evidence weights
- rationale
- A gene-specific evidence input calibration relevant to BRCA review; it does not measure full clinical classification or review effort.
- constraints
- Domain-restricted missense variants.; Functionally defined labels and calibration-selected cutpoints.
- limitations
- Independent pathogenicity labels, training overlap audit and serious-error adjudication remain missing.; No method-level clinical superiority claim.
- revision
- 1
- reason
- Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations.
- citation locators
- source id: uc-clinical-20260930-source-enigma; locator: Table 2 and footnotes a–c
- source locator
- uc-clinical-20260930-source-enigma: Table 2 and footnotes a–c
- review
- method: automated-source-review; reviewer: codex; reviewer note: Codex source curation, independent worker cross-review and root integration review; reviewed at: 2026-09-30T21:54:30.217Z; note: Source-backed literature curation with independent automated transcription and scope checks. No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
- reviewed evaluations
- uc-clinical-20260930-enigma-brca1-evaluation
- pins
- record id: uc-clinical-20260930-enigma-brca1-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: ae92d77920e453688ae1db43ec70587e3f973972b1e3155ad770536b35534ec3; record id: uc-clinical-20260930-enigma-brca1-high-benign-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d6ef1fdb6e9ffabd9c2737781e20ce026ad999bc14fcded102b8ef301eb0f18f; record id: uc-clinical-20260930-enigma-brca1-high-benign-fraction; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d5b113325ba7debb0ad1dcdc9188bd7c0c2d928813e0b3ac8d173ad666df1c87; record id: uc-clinical-20260930-enigma-brca1-high-likelihood-ratio; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: de5e1b45d523c714300e95c85abc6d9a971a9fa72e81d8775ef5d1562c4bee09; record id: uc-clinical-20260930-enigma-brca1-high-pathogenic-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 0e4705e1e7910be3b20dc5689c5f6f3fab987e10feacf2c81eed85675618120a; record id: uc-clinical-20260930-enigma-brca1-high-pathogenic-fraction; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: c938c5f34100a736835ec795f95966e7149be9cbc4ab13b07059d8c5aa6931ba; record id: uc-clinical-20260930-enigma-brca1-low-benign-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: fe4a27450a1ec02d777b0285165fa7eb18182e62377dd8f2ec0e7b730c06f1e9; record id: uc-clinical-20260930-enigma-brca1-low-benign-fraction; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 87b27645e62e08c6b6905de3c7075746eb4e60072da4d2af4589e95611936d4b; record id: uc-clinical-20260930-enigma-brca1-low-likelihood-ratio; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 6e17312cfa4d1ab2aa8b588faff3bf923aac70fabe3341177acff9ec5bafeffc; record id: uc-clinical-20260930-enigma-brca1-low-pathogenic-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3dc9fb12778192f72c89c72e9c9d370f03dc2fef59cf919663789d5e8f8f8182; record id: uc-clinical-20260930-enigma-brca1-low-pathogenic-fraction; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 24bf2cfdd5e25dba0a125ab008fed13654789df339559a7c18365cc46bb9aa7c; record id: uc-clinical-20260930-enigma-brca1-middle-benign-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d2961e7bfeb9a9e18197b6a56638b9b835d50924d0af35b225e624b372b4d6b7; record id: uc-clinical-20260930-enigma-brca1-middle-benign-fraction; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 94ce5c2807da4ebf7ca4059a42a39cc34ea8c96dda8d1a00a1556a3504e868d9; record id: uc-clinical-20260930-enigma-brca1-middle-likelihood-ratio; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 7e8267648227e1894fa4177f09eeae9176b0ac1e99a7c215ec568aa44cbca47e; record id: uc-clinical-20260930-enigma-brca1-middle-pathogenic-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d42248dac7c914461419ae1a18e9a59329c534388bba9c84373f2b6dfab6c931; record id: uc-clinical-20260930-enigma-brca1-middle-pathogenic-fraction; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 782dbba0825afb4bf280624147a019e770f1406884ba9aff7744afc2e4a07ea7; record id: uc-clinical-20260930-enigma-brca1-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: 93d28bb9883512932f100d6cc1bb591d1e6c88557195a0263a710448ca0e15ae; record id: uc-clinical-20260930-source-enigma; fields: status; attributes.artifact_sha256; sha256: 98137d62503a5f20532852f6a20517afeaacd0b0ae8e36dfccc9a48385284528; record id: use-case-brca1-brca2-germline-interpretation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd